Precede Biosciences
Kristian Cibulskis is an accomplished computational biologist and leader in bioinformatics engineering, currently serving as Senior Director at Precede Biosciences since February 2023. With nearly two decades of experience at the Broad Institute of MIT and Harvard, roles included Director of Technology, leading innovative projects that integrated science and cloud technology, and Assistant Director of Informatics for the Cancer Genome Analysis Group, where significant contributions included the development of leading-edge data analysis platforms and methods. Cibulskis has a strong track record in optimizing data processing pipelines, launching diagnostic infrastructure during the COVID-19 pandemic, and authoring influential cancer genome analysis methods. Prior technical leadership roles at deNovis, Sun Microsystems, Vertica Systems, and Sapient Corporation highlight expertise in software development and engineering. Cibulskis holds a BS in Computer Science from Cornell University.
This person is not in any teams
This person is not in any offices
Precede Biosciences
1 followers
We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test uncovers actionable disease-defining transcriptional biology. Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual genes and pathways in diseased tissues from just 1mL of plasma. By partnering with developers of new medicines and advancing our own diagnostic tests, we’re working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment that’s precise to the biology of their disease.